FREE Daily Stock Alerts From Stock-PR.com
Majestic Gold Corp. (TSX-V:MJS) recently announced the results of an updated resource estimate on its Song Jiagou Mine.
As part of the ongoing assessment on the Song Jiagou Mine, Wardrop Engineering Inc. has revised their previous resource estimate (NR 23 April, 2010) as a result of the revision to the contract mining costs (NR 30 September 2010) which allowed cut-off grades to be reduced from 0.40 g/t to 0.30 g/t and warranted a revision of the block model.
Subsequent to the initial resource estimate, Wardrop determined that rotating the block model perpendicular to drilling direction was the most favorable orientation to evaluate the deposit and to calculate the revised resource. The new cut-off grade and the re-orientation of the model significantly increased the overall size of the resource and the contained ounces of gold in both the inferred and indicated categories.
China has a long history of gold production. As early as 1091 BC, gold was legalized as money (as an alternative to silk), circulating in little squares. Hebei province, one of the main mining areas, claims production for over three thousand years. The Zhao Yuan mine in Shandong province has been worked for over a thousand years; other Shandong mines date from the 17th century.
After more than a century on the throne, South Africa has been deposed as the world's biggest producer of gold, with its estimated 2007 output, of 272 tonnes, falling just short of the 276 tonnes of the yellow metal produced by the new number one, China. While Chinese gold production increased by an estimated 12% year-on-year, South African mines produced 8% less gold than in 2006, according to precious metals consultancy GFMS's 'Gold Survey 2007 - Update 2'.
Compared to other countries, China's resource sector is relatively underdeveloped. A historical lack of investment capital and new technologies has prevented many of its quality properties from being fully explored or developed. China is now establishing an open policy to encourage foreign investment in gold exploration and mining. In March 2003, the National Development and Reform Commission (NDRC) was formed and soon established new regulations for exploration and mining licenses similar to those of Australia and North America.
By December 2003, the Chinese State Council published "China's Policy on Mineral Resources". The overall objectives of the policy are to: depend on and encourage the exploitation and exploration of China's own mineral resources; increase China's domestic capability of mineral resource supply; import foreign capital and technology; and, to help Chinese mining enterprises and mineral products enter the international market. In mid 2003 the Shanghai Gold Exchange was also established, operating as a free-market forum for gold trading and pricing.
Crown Equity Holdings Inc. (OTCPK:CRWE)
Crown Equity Holdings Inc. (OTCBB:CRWE) just recently announced that its subsidiary company, Crown Tele Services Inc. (http://www.crownteleservices.com ) is still moving forward after dissolving its joint venture with Communication Expert Corporation and will gradually start rolling out its internet based voice and video service IP-PBX solutions next year.
The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communication solutions specifically designed to meet the market needs.
Commenting on the venture, Kenneth Bosket, president said, “We are still excited with this opportunity to expand our footprint in this valuable market. The demand for internet-based voice and video services is growing exponentially and our new subsidiary Crown Tele Services Inc. has launched its new website and intends to emerge as a service provider of choice.”
According to ABI Research, the latAest global business VoIP services forecasts show that the value of the overall market, which includes VoIP integrated access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is set to double over the next five years, to exceed $20 billion by 2015.
Crown Equity Holdings Inc. (OTCBB:CRWE) reported its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. The Company incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by the Company.
“Our continued progress in operations including an operating profit of $7,251 during the last quarter shows a continued growth in our business,” commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. “Not only do our financial results show strong growth during this year but our continued investment in infrastructure will support our future growth,” stated Bosket.
Crown Equity Holdings Inc. is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.
Spherix Inc. (Nasdaq:SPEX) announced that its President, Dr. Robert Lodder, will be presenting at both OneMedForum SF 2011 and Biotech Showcase 2011. Dr. Lodder will deliver the Company's corporate presentation at two upcoming prestigious finance conferences to be held in San Francisco, CA, next week. Ms. Leisa Dennehy, Commercial and Corporate Development Advisor, will be attending the convention with Dr. Lodder and will be leading the business development activities for Spherix. OneMedForum SF 2011, presentation on January 11, 2011, 11:00 a.m. PST, with webcast at http://www.ustream.tv/channel/onemedforum.
Spherix Incorporated, together with its subsidiaries, operates as a scientific research company. It is developing D-tagatose that is in Phase 3 clinical trial for the treatment of type 2 diabetes. The company also provides scientific and strategic support for suppliers, manufacturers, distributors, and retailers of conventional foods, biotechnology-derived foods, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides.
iGo, Inc. (Nasdaq:IGOI) announced that Michael D. Heil, CEO, and Darryl Baker, CFO, will be presenting at the 13th Annual Needham Growth Stock Conference on Wednesday, January 12, 2011 at 9:20 a.m. EST. The conference is being held at the New York Palace Hotel in New York City. iGo will webcast its live presentation. To access the webcast, please visit the Company’s website at http://corporate.igo.com and go to the Investor Relations Web page. An archived version of the presentation will be available in the same location.
iGo, Inc. and its subsidiaries engage in the design, development, manufacture, and distribution of power products for high-power and low-power mobile electronic devices. The company’s products include AC/DC universal power adapters, DC-only power adapters, AC-only power adapters, DC cigarette lighter adapters, mobile AC adapters, combination AC/DC adapters, and battery-powered adapters.
Curis Inc. (Nasdaq:CRIS) announced that the Company has selected CUDC-907, an orally available, synthetic small molecule inhibitor of phosphatidylinositol-3-kinase (PI3K) and histone deacetylase (HDAC) as a development candidate from its targeted cancer programs. "We are pleased to announce the addition of CUDC-907 to our growing proprietary portfolio of innovative targeted cancer development programs. We believe that this compound, along with previously selected candidates CUDC-101, our EGFR, Her2 and HDAC inhibitor that is currently in Phase Ib testing, and CUDC-305, an HSP90 inhibitor that we licensed to Debiopharm and is currently in Phase I testing, continue to provide validation of the quality of our science and our efforts for developing innovative next generation targeted cancer therapies against a wide range of cancer types,” said Curis President and CEO Dan Passeri. “We expect to initiate IND-enabling studies for CUDC-907 shortly and following a favorable outcome, anticipate that we will file an IND application in late 2011.”
Curis, Inc., a drug discovery and development company, focuses on the research and development of cancer therapeutics. The company, under collaboration with Genentech, Inc., is conducting a pivotal Phase II clinical trial on its lead molecule, GDC-0449 in advanced basal cell carcinoma patients, as well as various Phase II clinical trials in first-line metastatic colorectal cancer and advanced ovarian cancer patients.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from a third party for (thirty) days of advertising for Majestic Gold Corp, TSX Venture Exchange (TSX.V:MJS) and the Frankfurt Stock Exchange (FSE:MJT).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.